Skip to Content
COVID-19 Resources
NCI Formulary
Contact NExT
Show menu
Search this site
Last Updated: 06/11/21

Selected Staff Publications

Jia L, Lu W, Niemtzow RC, Crawford P, Greenlee H, Ma Q, Mao JJ, Lin Y, Olaku O. A Virtual Roundtable Discussion Highlighting the Latest Acupuncture Research and Practice. Med Acupunct. 2020 Dec 1;32(6):336-344. doi: 10.1089/acu.2020.29158.rtl. Epub 2020 Dec 16.

Salicrup LA, Ossandon M, Prickril B, Rasooly A. Bugs as Drugs, potential self-regenerated innovative cancer therapeutics approach for global health. J Glob Health. 2020 Jun;10(1):010311. doi: 10.7189/jogh.10.010311.

Daschner PJ, Rasooly A, White JD. Bugs as Cancer Drugs: Challenges and Opportunities. Mol Cell Biol. 2019 Jul 16;39(15):e00206-19. doi: 10.1128/MCB.00206-19.

Curran CS, Rasooly A, He M, Prickril B, Thurin M, Sharon E. Report on the NCI Microbial-Based Cancer Therapy Conference. Cancer Immunol Res. 2018 Feb;6(2):122-126. doi: 10.1158/2326-6066.

Riscuta G, Xi D, Pierre-Victor D, Starke-Reed P, Khalsa J, Duffy L. Diet, Microbiome, and Epigenetics in the Era of Precision Medicine. Methods Mol Biol. 2018;1856:141-156. doi: 10.1007/978-1-4939-8751-1_8.

Zia FZ, Olaku O, Bao T, Berger A, Deng G, Fan AY, Garcia MK, Herman PM, Kaptchuk TJ, Ladas EJ, Langevin HM, Lao L, Lu W, Napadow V, Niemtzow RC, Vickers AJ, Shelley Wang X, Witt CM, Mao JJ. The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps. J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52):lgx005. doi: 10.1093/jncimonographs/lgx005.

Xi D, Bao T, Chen Q, Chen S, Cheng YC, Cullen J, Frank DA, Friedberg JW, Kronish I, Lee JE, Levine M, Li P, Li S, Lu W, Mao JJ, O'Keefe S, Rubinstein L, Shah MA, Standish L, Paller CJ, Chu E. State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report. J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52):lgx003. doi: 10.1093/jncimonographs/lgx003.

Olaku, O., Zia, F., Santana, J.M., & White, J.D. (2013). The National Cancer Institute Best Case Series Program: A summary of cases of cancer patients treated with unconventional therapies in India. Integrative Cancer Therapies, ahead of print

Olaku, O. (2013). Addition of certain herbal medicines to chemotherapy may increase survival and quality of life in patients with advanced colorectal cancer. Evidenced-Based Nursing,16(1), 14-15.

Jia, L. (2012). Cancer complementary and alternative medicine research at the US National Cancer Institute. Chinese Journal of Integrative Medicine, 18(5),325-32.

Nakayama, A., Alladin, K.P., Igbokwe, O. & White, J.D. (2011). Systematic Review: Generating Evidence-Based Guidelines on the Concurrent Use of Dietary Antioxidants and Chemotherapy or Radiotherapy. Cancer Investigation, 29(10), 655-667

Olaku, O. & White, J.D. (2011).Herbal therapy use by cancer patients: A literature review on case reports. European Journal of Cancer,47(4), 508-514.

White J. (2010). The Challenge of Rational Development of Complex Natural Products as Cancer Therapeutics. Journal of the National Cancer Institute, 102(12), 834-835.

Zia, F. & White, J.D.(2009). Letter to the Editor. Integrative Cancer Therapies, 2009,8(2),113-114.

Lee C., Zia F., Olaku O., Michie J., White J. (2009). Survey of CAM practitioners regarding cancer management and research. Journal of the Society of Integrative Oncology, 7(1), 26-34.

Smith W.B., Olaku O., Michie J., White J.(2008). Survey of cancer researchers regarding complementary and alternative medicine. Journal of the Society for Integrative Oncology, 16(1), 2-12.

Buchanan DR, White J.D., O'Mara AM, Kelaghan JW, Smith WB, Minasian LM. (2005). Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: Lessons from the National Cancer Institute Community Clinical Oncology Program experience. Journal of Clinical Oncology, 23(27), 6682-9.